Search Results for "free ce"

Maria is a Black nurse who has worked at her institution’s cancer center for several years. She enjoys educating her colleagues about burnout and well-being to create a happier and healthier work environment and actively supports the institution’s diversity, equity, and inclusion committee priorities and Black, Indigenous, and people of color nurses in practice.

Access and reimbursement, patient and provider education, core competencies, and survivorship research funding remain critical barriers for primary central nervous system cancer survivorship, a team of National Cancer Institute Comprehensive Oncology Network Evaluating Rare CNS Tumors experts reported in a workshop summary published in Neuro-Oncology Advances.

In a clinical trial of 65 patients with metastatic or recurrent Merkel cell carcinoma who had not previously received systemic therapy for advanced disease, treatment with retifanlimab-dlwr (Zynyz™) achieved a 52% overall response rate and 18% complete response rate, leading the U.S. Food and Drug Administration to grant it accelerated approval in March 2023.

Adolescent and young adults (AYAs)—those diagnosed between the ages of 15 and 39—comprise about 5% of all annual cancer diagnoses. The population has unique challenges that must be considered as part of patient-centered survivorship care planning.

As ONS enters 2020 celebrating both its 45th anniversary and the World Health Organization’s Year of the Nurse, the ONS Board of Directors is positioning the Society for a tremendous year. For its first meeting on January 28, 2020, the Board discussed a number of items critical to its mission and the future of oncology nursing.  

Lab-developed antibodies using a single-chain diabody format can target TP53 or RAS variants in solid tumors and T-cell receptor (TCR) variants in blood cancers, researchers reported in study findings published in Science, Science Immunology, and Science Translational Medicine, respectively.

The U.S. Food and Drug Administration (FDA) first approved atezolizumab (Tecentriq®) in 2016, but it received additional approvals when used in combination treatments for locally advanced or metastatic triple negative breast cancer (TNBC) and small cell lung cancer (SCLC) in March 2019. 

The World Health Organization designated 2020 internationally as the Year of the Nurse and Midwife in honor of Florence Nightingale’s 200th birthday. To celebrate the work that nurses do globally, nursing organizations around the world are creating programs that offer recognition—as well as education, training, and professional development.